Clusin W T, Buchbinder M, Ellis A K, Kernoff R S, Giacomini J C, Harrison D C
Circ Res. 1984 Jan;54(1):10-20. doi: 10.1161/01.res.54.1.10.
Calcium channel blockers suppress early ischemic arrhythmias, possibly by diminishing intracellular calcium overload and its effect on the ventricular action potential. To explore this, we compared the effects of diltiazem on ischemic "injury" potentials and ventricular fibrillation during serial coronary artery occlusions in dogs. Injury potentials and ventricular fibrillation were elicited every 15-25 minutes by simultaneous occlusion of the left anterior descending and circumflex arteries during rapid atrial pacing. DC epicardial electrograms were recorded differentially between the ischemic region and a small nonischemic region supplied by a proximal branch of the left anterior descending artery. Injury potentials developed with a uniform time course during five control occlusions, but were reduced by diltiazem infusion (0.5 mg/kg over 25 minutes) in each of eight dogs. The mean diastolic injury potential (T-Q depression) at 150 seconds of ischemia was 9.1 +/- 2.7 mV before diltiazem and 6.1 +/- 1.6 mV afterward (P less than 0.001). Diltiazem increased the mean time between coronary occlusion and ventricular fibrillation from 186 to 366 seconds (P less than 10(-5), but did not change the magnitude of the diastolic injury potential at onset of ventricular fibrillation. Diltiazem also delayed ischemia-induced conduction impairment to the same extent that it delayed injury potential development. In five dogs, the effect of diltiazem on regional blood flow near the epicardial electrodes was measured by infusion of radionuclide-labeled microspheres. Coronary occlusion reduced flow to the ischemic zone from 0.86 to 0.05 ml/min per g (P = 0.001). Diltiazem increased preocclusion flow by 11% (P = 0.03), but did not significantly alter flow during occlusion. Hemodynamic measurements show that diltiazem did not diminish cardiac work. Diltiazem therefore produced a flow-independent reduction of cellular depolarization during ischemia, which may be due to relief of calcium overload, and which may explain the antifibrillatory effect.
钙通道阻滞剂可抑制早期缺血性心律失常,可能是通过减少细胞内钙超载及其对心室动作电位的影响来实现的。为了探究这一点,我们比较了地尔硫䓬在犬类冠状动脉连续闭塞期间对缺血“损伤”电位和心室颤动的影响。在快速心房起搏过程中,通过同时闭塞左前降支和回旋支动脉,每隔15 - 25分钟诱发一次损伤电位和心室颤动。在缺血区域和由左前降支近端分支供血的小非缺血区域之间进行差分记录直流心外膜电图。在五次对照闭塞期间,损伤电位以均匀时间进程发展,但在八只犬中的每只犬中,地尔硫䓬输注(25分钟内0.5mg/kg)均使其降低。缺血150秒时的平均舒张期损伤电位(T - Q压低)在给予地尔硫䓬前为9.1±2.7mV,之后为6.1±1.6mV(P<0.001)。地尔硫䓬使冠状动脉闭塞至心室颤动的平均时间从186秒增加到366秒(P<10⁻⁵),但未改变心室颤动发作时舒张期损伤电位的幅度。地尔硫䓬延迟缺血诱导的传导障碍的程度与延迟损伤电位发展的程度相同。在五只犬中,通过输注放射性核素标记的微球来测量地尔硫䓬对心外膜电极附近局部血流的影响。冠状动脉闭塞使缺血区血流从0.86ml/min per g降至0.05ml/min per g(P = 0.001)。地尔硫䓬使闭塞前血流增加11%(P = 0.03),但在闭塞期间未显著改变血流。血流动力学测量表明地尔硫䓬并未减少心脏做功。因此,地尔硫䓬在缺血期间产生了与血流无关的细胞去极化减少,这可能是由于钙超载的缓解,这可能解释了其抗纤颤作用。